The Gross Law Firm Urges Viatris Investors to Act Before June 3, 2025 Lead Plaintiff Deadline
Notice to Viatris Inc. Shareholders
This article serves to inform shareholders of Viatris Inc. regarding a crucial deadline concerning a potential class action lawsuit. The Gross Law Firm has officially issued a reminder for those who purchased shares during the designated class period to consider registering as lead plaintiffs by June 3, 2025.
Background Information
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company that arose from the merger of Mylan and Upjohn, a division of Pfizer. In a recent complaint, it has been brought to light that certain material information regarding the inspection results from Viatris' facility in Indore, India was not properly disclosed to investors. Claims are made against the defendants for allegedly downplaying the significance of an FDA warning letter, characterizing it instead as a mere
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.